First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study-Reference-Cited by-同舟云学术

First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study

Published:2017-10-04 Issue:3 Volume:121 Page:348-356
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Necchi Andrea¹^ORCID,Lo Vullo Salvatore²,Perrone Federica³,Raggi Daniele¹,Giannatempo Patrizia¹,Calareso Giuseppina⁴,Nicolai Nicola⁵,Piva Luigi⁵,Biasoni Davide⁵,Catanzaro Mario⁵,Torelli Tullio⁵,Stagni Silvia⁵,Togliardi Elena⁶,Colecchia Maurizio³,Busico Adele³,Gloghini Annunziata³,Testi Adele³,Mariani Luigi²,Salvioni Roberto⁵

Affiliation:

1. Department of Medical Oncology; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy

2. Clinical Epidemiology and Trials Organization Unit; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy

3. Department of Pathology and Laboratory Medicine; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy

4. Department of Radiology; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy

5. Urology Unit; Department of Surgery; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy

6. Pharmacy Unit; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy

Funder

Pfizer

Fondazione IRCCS Istituto Nazionale dei Tumori

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14013/fullpdf

Reference29 articles.

1. Emerging systemic therapies for the management of penile cancer;Gupta;Urol Clin North Am,2016

2. EAU guidelines on penile cancer: 2014 update;Hakenberg;Eur Urol,2015

3. National Comprehensive Cancer Network : NCCN guidelines: Penile cancer https://www.nccn.org/professionals/physician_gls/pdf/penile.pdf

4. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study;Pagliaro;J Clin Oncol,2010

5. Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001);Nicholson;Br J Cancer,2013

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study;The Oncologist;2024-09-02

2. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization;European Urology;2024-08

3. Overview of Systemic Therapies in Penile Cancer;Urologic Clinics of North America;2024-08

4. New Therapeutic Horizons for Advanced or Metastatic Penile Cancer;Urologic Clinics of North America;2024-08

5. Penile cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up;ESMO Open;2024-07